Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $0.47 in the prior trading day, Harvard Bioscience Inc (NASDAQ: HBIO) closed at $0.45, down -3.51%. In other words, the price has decreased by -$3.51 from its previous closing price. On the day, 0.63 million shares were traded. HBIO stock price reached its highest trading level at $0.475 during the session, while it also had its lowest trading level at $0.4335.
Ratios:
Our goal is to gain a better understanding of HBIO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.71. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 0.49.
On March 10, 2023, The Benchmark Company Upgraded its rating to Buy which previously was Speculative Buy and also upped its target price recommendation from $3 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HBIO now has a Market Capitalization of 20028806 and an Enterprise Value of 58683060. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 1.35. Its current Enterprise Value per Revenue stands at 0.642 whereas that against EBITDA is 19.759.
Stock Price History:
The Beta on a monthly basis for HBIO is 1.54, which has changed by -0.8387097 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, HBIO has reached a high of $3.60, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 8.34%, while the 200-Day Moving Average is calculated to be -67.80%.
Shares Statistics:
The stock has traded on average 12.10M shares per day over the past 3-months and 1457320 shares per day over the last 10 days, according to various share statistics. A total of 44.21M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 15.39% of the company’s shares, while institutions hold 58.50% stake in the company. Shares short for HBIO as of 1749772800 were 2831924 with a Short Ratio of 0.23, compared to 1747267200 on 1957393. Therefore, it implies a Short% of Shares Outstanding of 2831924 and a Short% of Float of 6.9299996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
